A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Dose Frequency Study of Intravenous Ketamine in Patients with Treatment-Resistant Depression

被引：0

作者：

Singh, Jaskaran ^{[1
]}

Fedgchin, Maggie ^{[1
]}

Daly, Ella ^{[1
]}

De Boer, Peter ^{[2
]}

Cooper, Kimberly ^{[3
]}

Lim, Pilar ^{[4
]}

Pinter, Christine ^{[5
]}

Murrough, James ^{[6
]}

Sanacora, Gerard ^{[7
]}

Shelton, Richard ^{[8
]}

Kurian, Benji ^{[9
]}

Winokur, Andrew ^{[10
,11
]}

Fava, Maurizio ^{[12
,13
]}

Manji, Husseini ^{[1
]}

Drevets, Wayne ^{[1
]}

Van Nueten, Luc ^{[2
]}

机构：

[1] Janssen Res & Dev LLC, Neurosci, Titusville, NJ USA

[2] Janssen Res & Dev LLC, Neurosci, Beerse, Belgium

[3] Janssen Res & Dev LLC, Clin Biostat, Spring House, PA USA

[4] Janssen Res & Dev LLC, Clin Biostat, Titusville, NJ USA

[5] Janssen Res & Dev LLC, GTM, Titusville, NJ USA

[6] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA

[7] Yale Univ, Sch Med, New Haven, CT USA

[8] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA

[9] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA

[10] Inst Living, Hartford, CT USA

[11] Univ Connecticut, Farmington, CT USA

[12] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA

[13] Harvard Univ, Sch Med, Boston, MA USA

来源：

关键词：

Ketamine; Treatment-Resistant Depression; Efficacy; Safety;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

144

引用

页码：44S / 44S

页数：1